Jilin Province Huinan Changlong Bio-pharmacy Company Limited (8049.HK) HKSE

Currency In HKD

AD

Valuation

Market Cap1.1B
Enterprise Value954.31M
P/E Ratio4.14
PEG Ratio0.45
Price/Sales Ratio1.01
Price/Book Ratio0.62
Enterprise/Revenue0.8
Enterprise/EBITDA2.44

Fiscal Year

Fiscal YearDecember 31, 2025
Most Recent QuarterJune 30, 2026

Profitability

Profit Margin0.24
Operating Margin0.29
AD

Management Effectiveness

Return On Assets0.1
Return On Equity0.16

Income Statement

Revenue901.87M
Revenue/Share1.98
Gross Profit757.67M
EBITDA294.19M
Net Income198.88M
Diluted EPS0.35

Balance Sheet

Total Cash902.41M
Total Cash/Share1.61
Total Debt399,926
Total Debt/Equity0
Current Ratio1.47
Book Value Per Share3.29

Price History

52-Week Change9.39
52-Week High3
52-Week Low1.82
Moving Average 50 Days2.37
Moving Average 200 Days2.27

Statistics

Average Volume87,066
Shares Outstanding560.17M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0.25
Trailing Annual Dividend Yield12.33
Payout Ratio0
Last Split FactorN/A
Last Split DateN/A
AD